Effect of Pyramidal Aerobic Training on Ventilatory Function in Cigarette Smokers
2026年8月13日 更新者：Tarek Taha Fathy、Cairo University
Statement of the problem:
Does the pyramidal aerobic training affect ventilatory function parameters in smokers?
Null hypothesis:
Pyramidal aerobic training has no significant effect on ventilatory function parameters (such as Forced Vital Capacity [FVC], Forced Expiratory Volume in one second [FEV₁], and Peak Expiratory Flow Rate [PEFR]) in adult smokers.
研究概览
地位
完全的
详细说明
This randomized controlled trial evaluates the effect of an eight-week pyramidal aerobic training program on ventilatory function in cigarette smokers.
Forty male cigarette smokers aged 18 to 28 years will be randomly allocated to either a pyramidal aerobic training group or a control group.
The intervention group will perform treadmill-based pyramidal aerobic training three times per week for eight consecutive weeks.
Each session will include a warm-up, pyramidal aerobic training with ascending and descending intensity levels, and a cool-down.
Training intensity will range from 20% to 80% of the participant's target heart rate calculated using the Karvonen formula.
Ventilatory function will be assessed by spirometry, while functional capacity, health-related quality of life, and smoking abstinence self-efficacy will also be assessed at baseline and after the intervention.
研究类型
介入性
注册 (实际的)
40
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
October City
-
Giza、October City、埃及
- Faculty of Physical Therapy, Ahram Canadian University
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
接受健康志愿者
不
描述
Inclusion Criteria:
- Cigarette smoker males aged from 18 to 28 years.
- Smoking index = 50.
- Sedentary lifestyle.
- BMI between 18.5 and 29.9 kg/m².
- Cigarette smokers demonstrate mild to moderate impairment in ventilatory function confirmed by baseline spirometry.
- SASEQ (Smoking Abstinence Self-Efficacy Questionnaire) moderate self-efficacy, score from 9 to 16.
- Cigarette smokers are able and willing to participate in aerobic training sessions
Exclusion Criteria:
- Patients diagnosed with chronic respiratory diseases such as asthma.
- Patients with cardiovascular diseases or other systemic illnesses that contraindicate exercise.
- Patients who experienced recent respiratory infections within the last 4 weeks.
- Patients currently engaged in regular structured aerobic or respiratory training programs.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Pyramidal Aerobic Training Group
Participants will receive pyramidal aerobic training on a treadmill three times per week for eight consecutive weeks.
|
Pyramidal aerobic training performed on a motorized treadmill three times per week for eight consecutive weeks.
Each session consists of 5 minutes of warm-up, 20 minutes of pyramidal aerobic training with 5 ascending and 5 descending intensity levels, each lasting 2 minutes, followed by 5 minutes of cool-down.
Training intensity ranges from 20% to 80% of the participant's target heart rate calculated using the Karvonen formula, with heart rate monitored using a pulse oximeter.
|
|
无干预：Control Group
Participants will be assigned to the control group.
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Forced Expiratory Volume in 1 Second (FEV1)
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
|
Forced Vital Capacity (FVC)
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
|
FEV1/FVC Ratio
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
|
Peak Expiratory Flow Rate (PEFR)
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Functional Capacity (VO2max)
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
|
|
Health-Related Quality of Life (SF-12)
大体时间：Baseline and after 8 weeks of intervention
|
Baseline and after 8 weeks of intervention
|
|
|
Smoking Abstinence Self-Efficacy Questionnaire (SASEQ) Score
大体时间：Baseline and after 8 weeks of intervention
|
Smoking abstinence self-efficacy will be assessed using the Smoking Abstinence Self-Efficacy Questionnaire (SASEQ).
The questionnaire score ranges from 9 to 16, with higher scores indicating greater smoking abstinence self-efficacy.
|
Baseline and after 8 weeks of intervention
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Tarek Taha Fathy、Cairo University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2025年9月6日
初级完成 (实际的)
2026年2月10日
研究完成 (实际的)
2026年4月15日
研究注册日期
首次提交
2026年8月10日
首先提交符合 QC 标准的
2026年8月13日
首次发布 (实际的)
2026年8月14日
研究记录更新
最后更新发布 (实际的)
2026年8月14日
上次提交的符合 QC 标准的更新
2026年8月13日
最后验证
2026年8月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.